2014

Medical Marijuana Inc. and the Dixie Elixirs and Edibles Brand will be on Fox News Geraldo at Large on December 8, 2012. Also links to Brooke Baldwin's CNN News Room interview with Mr. Keber that aired October 6th and highlights from Ted Caligiuri interview regarding a significant jump in MJNA stock prices.

SAN DIEGO, Dec. 7, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that its portfolio company, Red Dice Holdings, continues to  receive national media attention for its Dixie Elixirs & Edibles brand on the CNN "Washington State's New Pot Law Takes Effect." segment yesterday, December 6th.

Tripp Keber, President and CEO of Red Dice Holdings LLC, was interviewed yesterday by Brooke Baldwin on CNN News Room regarding the passage of several key marijuana legalization initiatives in Washington and Colorado and expansion plans for those markets. The interview can be heard at http://newsroom.blogs.cnn.com/2012/12/06/washington-states-new-pot-law-takes-effect/

Mr. Keber will also be featured on Fox News' Geraldo Rivera on Saturday night regarding legalization of marijuana as a milestone to end prohibition. To view that interview:  http://www.foxnews.com/on-air/geraldo/index.html

Also, Ted Caligiuri, Interim President of Medical Marijuana Inc. discusses the company's recently released Q3 financials in a new audio interview at SmallCapVoice.com. The interview can be heard at http://smallcapvoice.com/blog/12-4-12-smallcapvoice-interview-with-medical-marijuana-inc-mjna

During the interview Mr. Caligiuri also discusses the exciting growth in the entire medical marijuana market, the new markets the Company is exploring, the goals for MJNA in 2013, an update on the up listing efforts by the company and much more.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at:

www.MedicalMarijuanaInc.com

 

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:

Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE Medical Marijuana Inc.



RELATED LINKS
http://www.medicalmarijuanainc.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.